Navigation Links
Pharmaceutical and Medical Device Patent Portfolio Acquisition Opportunities from ICAP Patent Brokerage
Date:9/4/2013

NEW YORK, Sept. 4, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces innovative pharmaceutical and medical device patent portfolios available for sale via private brokerage.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

"­­­­­­­­­­­­­­­­­­­­­­­­­­We are thrilled to offer such strong patent portfolios disclosing key advancements for the medical and pharmaceutical industry. The cutting-edge inventions developed in this space and now available for sale have endless possibilities – most importantly improved medical care and enhanced quality of life – when matched with the right buyer," says Dean Becker, CEO of ICAP Patent Brokerage.

Patent Portfolios for Sale
The assets available for sale disclose key innovations relevant to these exciting technology sectors, including:

  • Material for Orthopedic Applications
  • Enhanced Topical Analgesic Cream
  • and more!

Click here to see a complete catalog of the pharmaceutical and medical device patent portfolios available for sale.

To learn more about the assets available for sale:
Contact Paul Greco of ICAP Patent Brokerage at (212) 815-6692 or via email at Paul.Greco@us.icap.com.

Follow us on Twitter (@ICAP_Auction_IP) and join our

SOURCE ICAP Patent Brokerage
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
2. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
3. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
4. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
5. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
6. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
7. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
8. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
9. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
10. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
11. Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value across a Diverse Set of Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  Kinex Pharmaceuticals announced the receipt of ... KX2-391 Ointment for the commencement of a Phase I ... third IND to be allowed by the US FDA ... a synthetic, orally active and highly selective inhibitor of ... the induction of p53, G2/M arrest of proliferating cell ...
(Date:7/24/2014)... -- Talyst, a market leader in pharmacy automation, will ... Veterans Homes (NASVH) Summer Conference in Charleston, ... is to ensure that each and every eligible US ... and respect which they have earned by their service ... Dispensing System, Talyst can help State Veterans Homes increase ...
(Date:7/24/2014)... , July 24, 2014  The American ... is supporting its mission to help address audit ... and exclusive agreement to be the information technology ... As the leading provider of billing and business ... unmatched HME industry expertise to support this important ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2
... Imaging announced today that it has received FDA 510(k) ... Analyzer® System to assess coronary branch vessels in addition ... artery disease (CAD). The clearance is the third for ... tool that automatically detects significant (50 percent and over) ...
... Medical, Inc., a private sports medicine device company specializing ... immediately, David B. Springer will succeed James Hart as ... Executive Chairman due to health reasons. Hart, ... CEO since the company,s inception in 2005, will continue ...
Cached Medicine Technology:Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 3
(Date:7/24/2014)... York, NY (PRWEB) July 24, 2014 For the ... touring across the United States. The Scottish singer first became a ... Britain’s Got Talent. Her first song on the show was “I ... history. She has released five studio albums since her time on ... enough to perform in front of her American fans. The tour ...
(Date:7/24/2014)... The report, “Feed Palatability Enhancers & Modifiers Market by ... Pets, Aquaculture, and Others) - Global Trends & Forecasts ... & modifiers market with an analysis and projection of ... of feed flavors, sweeteners, and text rants. , Browse ... 275 pages and in-depth TOC on "Feed Palatability Enhancers ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 The North American ... the omega 3 & structured lipids market in North America ... America is estimated to grow from around $762.4 million in ... 6.6% from 2013 to 2018. , Browse through the TOC ... report, to get an idea of the in-depth analysis provided. ...
(Date:7/24/2014)... percent of all prenatal ultrasounds uncover antenatal hydronephrosis, ... abnormality in the United States. Many children with ... for the first few years of life with ... tract infections. Until recently, however, little evidence existed ... involves considerable cost and inconvenience for families. But ...
(Date:7/24/2014)... Skin Cancer cells work together to spread further and ... Reports. The discovery could lead to new drugs to ... , Cancer Research UK scientists at The University of ... growing, but not very good at invading the surrounding ... highly invasive but slow-growing. , In a tumour, ...
Breaking Medicine News(10 mins):Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 2Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 3Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 4Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 2Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 4Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 5Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:Piggy-backing cells hold clue to skin cancer growth 2
... , , , , , , ... Medical,International Limited (NYSE: MR ), a leading developer, ... at its annual general meeting of shareholders held in Hong ... the meeting, Mindray Medical International,s shareholders approved the,re-election of directors ...
... causes more pain than vodka, study finds , FRIDAY, Dec. ... a common indulgence -- and nasty hangovers a common consequence. ... lighter-colored beverages, they might feel a little better the next ... contain more toxic properties that provoke more painful hangovers than ...
... , , , NEWPORT BEACH, Calif., Dec. 18 ... announced today that it has given notice that it is ... Cumulative Convertible Preferred Stock ("Series B Preferred Stock") (NHP-PB - ... price per share of $103.875 plus an amount equal to ...
... thoughts may help explain interpersonal problems , FRIDAY, Dec. ... are less active than expected when they,re engaged in ... difficulties, say British researchers. , Using functional MRI, they ... whom had autism, while they were asked questions about ...
... CentraCare president is new chair , ST. PAUL, Minn., Dec. ... systems, recently elected or re-elected the following members to its board for ... Chair - Terence Pladson, M.D., president, CentraCare Health System, ... CEO, Queen of Peace Hospital, New Prague, Secretary/treasurer - ...
... , , HOUSTON, Dec. 18 ... largest provider of deathcare products and services in North America, ... has extended the expiry time of its offer (the "Offer") ... and outstanding common shares in the capital of Keystone North ...
Cached Medicine News:Health News:Mindray Medical International Limited Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 2Health News:For a Lighter Hangover, Avoid Darker Drinks 2Health News:For a Lighter Hangover, Avoid Darker Drinks 3Health News:For a Lighter Hangover, Avoid Darker Drinks 4Health News:Nationwide Health Properties, Inc. Announces the Redemption of All Outstanding Shares of 7.75% Series B Cumulative Convertible Preferred Stock 2Health News:Brain Imaging Sheds Light on Social Woes Related to Autism 2Health News:Minnesota Hospital Association Elects, Re-Elects Members to Board 2Health News:Service Corporation International Extends Offer for Keystone North America Inc. 2Health News:Service Corporation International Extends Offer for Keystone North America Inc. 3
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Fenestrated 14 mm blades and canthus bar. Adjustable blade locking screws on outside of branches. Dull finish....
Double bent ends prevent wire from catching when pushed forward. Designed for use with the Castroviejo Snare (E3675). Package of 12 stainless steel wires. Overall length 4.3 inches....
Replacement snares for the E3525. 3 per package....
Medicine Products: